Fast Money 5/16/25
CNBC's "Fast Money"
00:00
Challenges and Opportunities in the Weight Loss Drug Market
This chapter discusses the impacts of Novo Nordisk's CEO ousting on its stock and R&D amidst stiff competition in the weight loss sector. The conversation analyzes the company's future strategies and its potential to regain market dominance compared to Eli Lilly.
Play episode from 27:42
Transcript
